Snowball logo
logo
CORT_logo

Corcept Therapeutics Incorporated

$32.15-$0.240003  (0.74%)

Frequently asked questions

What sector does Corcept Therapeutics Incorporated (CORT) operate in?

Corcept Therapeutics Incorporated belongs to the Healthcare sector and operates in the Biotechnology industry.

What is Corcept Therapeutics Incorporated (CORT) current stock price?

As of the latest data, Corcept Therapeutics Incorporated stock price is $32.15, with a previous close of $32.39. Corcept Therapeutics Incorporated lost -$0.24 in the last trading session, representing a -0.74% loss.

What is Corcept Therapeutics Incorporated (CORT) current market capitalization?

Corcept Therapeutics Incorporated market cap is approximately 3.38 billion.

What is Corcept Therapeutics Incorporated (CORT) Earnings Per Share (EPS)?

The trailing EPS is $0.87, and the forward EPS is $0.50.

What is Corcept Therapeutics Incorporated (CORT) Price-to-Earnings (P/E) ratio?

Corcept Therapeutics Incorporated current P/E ratio is 36.95, with a forward P/E of 64.56.

What is Corcept Therapeutics Incorporated (CORT) EBITDA?

Corcept Therapeutics Incorporated EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 15.72 million.

Does Corcept Therapeutics Incorporated (CORT) pay dividends?

No. Corcept Therapeutics Incorporated does not pay a dividend.

How did Corcept Therapeutics Incorporated (CORT) perform in its most recent earnings report?

In the last report (December 31, 2025), Corcept Therapeutics Incorporated posted an EPS surprise of 23.08% and a revenue surprise of -4.98%.

When is Corcept Therapeutics Incorporated (CORT) next earnings report?

Corcept Therapeutics Incorporated is expected to release its next earnings report on March 31, 2026.

What is Corcept Therapeutics Incorporated (CORT) beta (volatility) score?

Corcept Therapeutics Incorporated has a beta of 0.264, indicating lower volatility than the overall market.